Roche Analyst Event at ASCO 2018 Replay
Roche has hosted an analyst briefing to discuss data presented on the Roche Group’s oncology products and pipeline at the American Society of Clinical Oncology Annual Meeting (ASCO) in Chicago (1 – 5 June 2018).
Highlights in cancer immunotherapy
Alan Sandler, M.D., a.i. Global Head Oncology, Global Head Lung Cancer Franchise
Biomarkers in the era of cancer immunotherapy
Priti S. Hegde, Ph.D., Oncology Biomarker Development
Highlights late stage portfolio outside cancer immunotherapy
Sandra Horning, M.D., Chief Medical Officer and Head Global Product Development
Oncology strategy and impact on patients
Daniel O’Day, CEO Roche Pharmaceuticals
Video Webcast Replay
Please fill out the form to access the Video Webcast.